Huimian Xu

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Feng‐Hua Wang, Lin Shen, Jin Li et al. · Cancer Communications · 2019 · 851 citations · Full text

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

Feng‐Hua Wang, Xiao‐Tian Zhang, Yuanfang Li et al. · Cancer Communications · 2021 · 645 citations · Full text

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 414 citations

D2 Gastrectomy, Surgical Oncology, Esophageal Cancer +10

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

Yongxi Song, Zhenyu Yue, Zhenning Wang et al. · Molecular Cancer · 2011 · 400 citations · Full text

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang et al. · Cancer Communications · 2023 · 328 citations · Full text